INOTREM has a total of 12 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement and biotechnology are COMBISEP INC, SUZHOU HAOOUBO BIOPHARMACEUTICAL CO LTD and WEIHAI NEOPROBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | China | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Russian Federation | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Boufenzer Amir | 12 |
#2 | Derive Marc | 12 |
#3 | Simon Tabasomme | 10 |
#4 | Danchin Nicolas | 10 |
#5 | Ait-Oufella Hafid | 9 |
#6 | Gibot Sebastien | 6 |
#7 | Gibot Sébastien | 4 |
#8 | Carrasco Kevin | 2 |
#9 | Koch Martin | 2 |
#10 | Salcedo-Magguilli Margarita | 2 |
Publication | Filing date | Title |
---|---|---|
CA3114503A1 | Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy | |
EP2835641A1 | Methods and kits for predicting the risk of having a cardiovascular disease or event |